Cell-Free DNA as a Prognostic Biomarker for Monitoring Muscle-Invasive Bladder Cancer

Cell-free DNA (cfDNA) has recently emerged as a real-time biomarker for diagnosis, monitoring and prediction of therapy response in tumoral disease. Here, we evaluated cfDNA as a prognostic biomarker for monitoring muscle-invasive bladder cancer (MIBC) patients at different follow-up time points. Bl...

Descripción completa

Detalles Bibliográficos
Autores principales: Carrasco, Raquel, Ingelmo-Torres, Mercedes, Gómez, Ascensión, Trullas, Ramón, Roldán, Fiorella L., Ajami, Tarek, Moreno, Davinia, Rodríguez-Carunchio, Leonardo, Alcaraz, Antonio, Izquierdo, Laura, Mengual, Lourdes
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570339/
https://www.ncbi.nlm.nih.gov/pubmed/36233035
http://dx.doi.org/10.3390/ijms231911732

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9570339/
https://www.ncbi.nlm.nih.gov/pubmed/36233035
http://dx.doi.org/10.3390/ijms231911732

Ejemplares similares